MSA
HZNP

Marino Stram & Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Marino Stram & Associates’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,715
Closed -$348K – 307
2021
Q2 		$348K Buy
+3,715
New +$342K 0.09% 182

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marino Stram & Associates's HZNP Position: Q3 2021 in Review

Marino Stram & Associates sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2021, closing a stake of 3,715 shares — an estimated $348K sold.

Marino Stram & Associates first reported a position in HZNP in Q2 2021 and held it in 1 quarter. The position peaked at $348K in Q2 2021. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

  • Marino Stram & Associates reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Marino Stram & Associates sold 3,715 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $348K.
  • Marino Stram & Associates first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 1 quarter.
  • Marino Stram & Associates's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $348K in Q2 2021.
  • 572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Marino Stram & Associates's 13F filing for Q3 2021, filed 14 Oct 2021.